1. Introduction {#sec1}
===============

Prioritization on prevention and promotion of health in dentistry, as well as for many other medical specialties, is of great importance to reduce the risk of infection of the most prevalent diseases \[[@B1]--[@B4]\]. In Peru, dental caries is a major oral health problem with a high prevalence in the population \[[@B5], [@B6]\].

Recent scientific breakthroughs have been able to determine that the main factor associated to this disease is the demineralization caused by the acidic by-products of oral fermenting bacteria. Therefore, acidophilic bacteria such as *Streptococcus mutans*, *Streptococcus sanguinis*, and *Lactobacillus* are required for dental decay to occur \[[@B7]--[@B12]\]. Various treatment options have been developed and are currently used in dentistry as first-line therapies for this condition. These include topical fluorine, fluoride varnish, toothpaste, and mouthwashes \[[@B2], [@B3]\].

Despite current means to diagnose and treat this condition, the prevalence of dental caries in Peru remains high. It is therefore necessary to develop new treatment alternatives that may complement current therapies. Phytotherapy research focuses on studying the medicinal properties offered by plants and vegetables substances, to treat and improve treatment outcomes of certain diseases \[[@B13]--[@B15]\].

*Pelargonium peltatum*, commonly known as ivy geranium, is a plant that was recently introduced to the field of dentistry. Even though its properties have been studied and applied in the field of medicine for the treatment of respiratory diseases such as bronchitis and sinusitis, few studies have evaluated its effectiveness against bacteria responsible for diseases of the oral cavity \[[@B16]--[@B18]\].

Given the high prevalence of dental caries in Peru, it is important to consider phytotherapy as a treatment alternative in the field of odontology. The purpose of this study was to evaluate the antibacterial and cytotoxic effects of the methanolic extracts of *P. peltatum* against *S. mutans* and *S. sanguinis*.

2. Materials and Methods {#sec2}
========================

2.1. Extract Preparation {#sec2.1}
------------------------

*P. peltatum* (ivy geranium) was acquired from the university herb garden of Universidad Nacional Agraria La Molina (UNALM) in the city of Lima, Peru. Three different extracts were prepared using the roots, stems, and leaves of the studied plant. These products were separated in different containers and immersed independently in absolute methanol (1 : 1 weight/volume). The samples were then stored at room temperature for 7 days without sunlight exposure. The 3 different extract solutions were filtered through Whatman® qualitative filter paper, grade 4 (20--25 *µ*m), and placed in labeled tubes. The tubes were distilled using a rotatory evaporator at 50°C to obtain a pure extract. The extracts were stored in 15 mL plastic tubes in a rack without sunlight exposure and at a temperature of 4°C until further use.

2.2. Bacterial Cultures {#sec2.2}
-----------------------

The anaerobic standard strains employed in the study were provided by the American Type Culture Collection: *S. mutans* (ATCC 25175) and *S. sanguinis* (ATCC 10556). These were identified by species and genre.

The bacteria were cultured on BHI (brain heart infusion) agar plates and incubated at 37°C for 72 hours in anaerobic conditions. We proceeded to isolate 3 to 4 colonies of which were later inoculated in a 3 mL BHI broth. The cultures were diluted in a sterile saline solution to a McFarland scale density of 0.5, which corresponds to a concentration of approximately 1.5 × 10^8^ UFC/mL \[[@B19]\].

2.3. Antibacterial Activity of Methanolic Extracts {#sec2.3}
--------------------------------------------------

The antibacterial effect was analyzed by means of the well diffusion method. We autoclaved the BHI agar medium plates at 121°C for 15 minutes. After cooling, the bacterial suspension was inoculated on the agar plates. A sterile cork borer was used to punch 8 mm-diameter wells which were then filled with 100 *µ*L of each extract. We used chlorhexidine 0.12% \[[@B20]\] as a positive control for each assay. The whole procedure was done in a laminar flow cabin in order to maintain sterile conditions. The agar plates were incubated in anaerobic conditions at 37°C for 48 days.

2.4. Determination of the Minimum Inhibitory Concentration (MIC) {#sec2.4}
----------------------------------------------------------------

The minimum inhibitory concentration of each extract was determined using the microdilution method following the recommendations by the Clinical Laboratory Standard Institute (CSLI, 2012) \[[@B21]\]. Each methanolic extract was diluted to concentrations ranging between 0 mg/mL to 500 mg/mL and then added separately to the wells. Then, 100 *µ*L of each bacterial suspension (0.5 McFarland scale) was added to these wells and then incubated at 37°C for 48 hours in anaerobic conditions. The minimum inhibitory concentration was defined as the minimum concentration of the extract required to inhibit bacterial growth.

2.5. Cytotoxicity Evaluation of *P. peltatum* {#sec2.5}
---------------------------------------------

### 2.5.1. Cell Line Cultures {#sec2.5.1}

The MDCK cell lines were obtained from ATCC (American Type Culture Collection). The cells were culture in an essential culture medium with Earle\'s salts (Gibco BRL, Grand Island, NY), enriched with fetal bovine serum at 10%, 25 *µ*g/L of gentamicin, and 200 mmol/L of L-glutamine (growth medium). The infected cells were stored in a minimum essential medium with fetal bovine serum at 1%, 25 *µ*g/L of gentamicin, and 200 mmol/L of L-glutamine (maintenance medium). All the cells were cultured at 37°C in a humidified atmosphere with 5% of CO~2~ and 95% air.

### 2.5.2. Cytotoxicity {#sec2.5.2}

An MTT reduction assay was used to determine the cytotoxicity of the extracts on MDCK cell lines. The cell lines were cultured on a sterile 96-well microtiter plate. Subsequently, we proceeded to distribute varying concentrations of each methanolic extract of *P. peltatum* onto the plate. The concentration of each extract ranged between 5 *µ*g/mL to 100 *µ*g/mL. A culture medium without any extract was used as the positive control for this cellular viability. The plate was incubated at 37°C for 6 days. The cellular viability of each extract was determined as a percentage of the absorbance obtained for each well in comparison with the positive control. The absorbance values (570 mm) were measured using a photometric reader.

3. Results {#sec3}
==========

3.1. Antibacterial Effect of *P. peltatum* Extracts {#sec3.1}
---------------------------------------------------

The results obtained from this study showed that the extracts had a significant antibacterial property. [Table 1](#tab1){ref-type="table"} shows that the root extract of *P. peltatum* had the highest antibacterial effect against *S. mutans* with an inhibitory zone of 27.68 mm followed by the leaf and the stem extracts with inhibitory zones of 25.85 mm and 23.97 mm, respectively.

On the other hand, the root extract had the highest antibacterial effect against *S. sanguinis* with a mean inhibitory zone of 30.8 mm followed by the leaf extracts with a mean value of 29.6 mm and finally the stem extract with 27.54 mm. We found statistically significant differences using the Kruskal--Wallis test (*p* \< 0.01).

3.2. Minimum Inhibitory Concentration {#sec3.2}
-------------------------------------

The minimum inhibitory concentration (MIC) of the methanolic extracts against *S. mutans* strains was 250 mg/mL for the leaf and root extracts and 125 mg/mL for the stem extracts. In contrast, the MIC of the root and leaf extracts against *S. sanguinis* was 125 mg/mL and 31 mg/mL for the stem extract ([Table 2](#tab2){ref-type="table"}).

3.3. Cytotoxicity of the *P. peltatum* Extract {#sec3.3}
----------------------------------------------

The results indicate that the methanolic extracts of *P. peltatum* inhibit 50% of cellular viability (CC~50~) at a higher concentration of 100 *µ*g/ml. Furthermore, none of the extracts produced any adverse effects on the MDCK cellular lines at low concentrations. We observed an indirect correlation between the concentration and cellular viability ([Figure 1](#fig1){ref-type="fig"}).

4. Discussion {#sec4}
=============

Medicine has evolved over the years providing the world with new therapies that contribute to the well-being of the population. Phytotherapy, the use of natural products as an alternative to treat different ailments, is being continually developed \[[@B13]\].

*S. mutans* and *S. sanguinis* are commonly parts of bacterial flora in the oral cavity. These microorganisms are required in the pathogenesis of certain prevalent diseases, such as dental caries \[[@B22]\]. Furthermore, these bacteria are also associated with periodontal disease and systemic disease such as bacteremia and endocarditis, as is the case for *S. sanguinis* \[[@B23]\].

In this study, we showed that the plant *P*. *peltatum* has high antibacterial properties against microorganisms responsible for prevalent diseases of the oral cavity. The results coincide with the data obtained by similar studies, such as Guerrero Hurtado et al. \[[@B24]\], in which the antibacterial effect of an aqueous extract of a geranium plant was evaluated against the strains of *S. mutans*, *S. sanguinis*, and *Streptococcus mitis* showing antibacterial effect of the extracts against all the studied strains. The antibacterial effect of *Pelargonium peltatum* can be explained by the antimicrobial activity of its phytoconstituents, which include flavonoids, tannins, steroids, anthocyanins, quinones, and saponins. Tannins were found in greater concentration in the roots and cortex of these plants and have shown to have effective antiseptic, antibacterial, and astringent properties \[[@B18], [@B25]\]. This could explain the higher antibacterial effect observed with root extracts.

It is worth noting that there are many species of the genus *Pelargonium*; other studies have analyzed the antibacterial activity of the plants belonging to this family but very few to the species used in this study. Ghannadi et al. \[[@B16]\] evaluated the antibacterial effect of two plants, one of them being *Pelargonium graveolens*, against 6 microorganisms and showed that 5 of them were susceptible to the oil extract of this geranium class.

Galea and Hancu \[[@B17]\] conducted a similar research showing the antibacterial effect of *Pelargonium roseum* against 6 strains of Gram-negative bacteria and the fungus *Candida albicans*, a dimorphic fungus included in the natural oral flora that causes disease in immunosuppressed patients.

The minimum inhibitory concentration (MIC) found in this study was found to be between 125 mg/mL to 250 mg/mL. We could not find studies that found the MIC of geranium against the microorganisms in this study. However, in a study conducted by Bigos et al. \[[@B18]\] in which geranium antibacterial effect was evaluated on strains of *Staphylococcus aureus*, it was observed that the MIC was 250 mg/mL, data similar to those obtained in this study.

We evaluated the cytotoxicity of the extracts against the cell line MDCK and observed promising results. The cytotoxicity assay showed a cell viability of 95.3%, 74.4%, and 80.4% for the root, stem, and leaf extracts, respectively, at high concentrations (100 *µ*g/mL). We could not find previously published studies on the cytotoxicity of these extracts.

Geranium is a plant that is easy to grow and is economically and logistically accessible \[[@B17]\] and that possess high antibacterial properties with low cytotoxicity at high concentrations. The use of this plant could be considered as a new alternative in the development of effective toothpastes or mouthwashes. Further experimental and clinical studies are required to guarantee its safety and to further evaluate the antibacterial properties *in vivo*.

The results in this study have demonstrated that the geranium plant has antibacterial properties associated with a low cytotoxicity, and furthermore, it has a low production cost and is readily accessible. These properties make the extracts of geranium promising candidates for the development of novel dental products.

5. Conclusions {#sec5}
==============

The findings in this study show that the methanolic extracts of *P. peltatum* (geranium) has effective antibacterial properties against strains of *S. mutans* and *S. sanguinis*. Additionally, we found that the root extracts had the greatest antibacterial effect in comparison with the leaf and stem extracts. The cytotoxicity assay showed a high cellular viability at high concentrations. We suggest further studies with this species of *Pelargonium* given that research is lacking on the matter.
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###### 

*In vitro* comparison of the antibacterial effect of the methanolic extracts of *Pelargonium peltatum* against strains of *Streptococcus mutans* and *Streptococcus sanguinis.*

  Microorganism               Extract   Inhibition zone (mm)                        
  --------------------------- --------- ---------------------- ------ ------ ------ --------
  *Streptococcus mutans*      Root      27.68                  0.97   25.5   28.8   \<0.01
  Leaf                        25.86     0.54                   24.6   26.3          
  Stem                        23.97     0.91                   22.5   25            
                                                                                    
  *Streptococcus sanguinis*   Root      30.8                   0.55   30     32.1   \<0.01
  Leaf                        29.26     0.76                   27.8   30.5          
  Stem                        27.53     1.13                   26     29.4          

^*∗*^Kruskal--Wallis test.

###### 

Minimum inhibitory concentration according to the methanolic extract of *Pelargonium peltatum* against strains of *Streptococcus mutans* (ATCC 25175) and *Streptococcus sanguinis* (ATCC 10556).

  Microorganism               Extract   Concentration (mg/mL)                                               
  --------------------------- --------- ----------------------- ----- ----- ----- ---- ----- ---- ----- --- ---
  *Streptococcus mutans*      Leaf      \+                      MIC   −     −     −    −     −    −     −   −
  Stem                        \+        \+                      MIC   −     −     −    −     −    −     −   
  Roots                       \+        MIC                     −     −     −     −    −     −    −     −   
  CHX                         \+        \+                      \+    \+    \+    \+   \+    \+   MIC   −   
                                                                                                            
  *Streptococcus sanguinis*   Leaf      \+                      \+    MIC   −     −    −     −    −     −   −
  Stem                        \+        \+                      \+    \+    MIC   −    −     −    −     −   
  Roots                       \+        \+                      MIC   −     −     −    −     −    −     −   
  CHX                         \+        \+                      \+    \+    \+    \+   MIC   −    −     −   

^*∗*^2CHX: chlorhexidine, MIC: minimum inhibitory concentration, (**+**): extract inhibit the visible growth of strains, (−): extract not inhibit the visible growth of strains.
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